A review of the safety of DHA45-oil

Food and Chemical Toxicology

Volumn 41, Issue 11, 2003, Pages 1433-1446

  Kroes, Robert ^a   Schaefer, Ernst J ^b   Squire, Robert A ^c   Williams, Gary M ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TUFTS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

DHA; DHA45 oil; Docosahexaenoic acid; Food ingredient; Marine protist; Safety; Toxicity; 3 Polyunsaturated fatty acid

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ACUTE TOXICITY; ALGA; CHRONIC TOXICITY; DIET SUPPLEMENTATION; DIETARY INTAKE; FATTY ACID METABOLISM; FERMENTATION; FISH; FOOD; FOOD COMPOSITION; FOOD SAFETY; GENOTOXICITY; HUMAN; MAMMAL; MEAT; MOUTH; NONHUMAN; NUTRITIONAL VALUE; ORGAN; PROCESSING; REPRODUCTIVE TOXICITY; REVIEW; SHELLFISH; TOXICITY TESTING; TOXICOLOGY;

MAMMALIA; PROTISTA;

EID: 0041379228     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(03)00163-7     Document Type: Review

References (121)

1. Achard F., Bénistant C., Lagarde M. Interconversions and distinct metabolic fate of eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in bovine aortic endothelial cells. Biochimica et Biophysica Acta. 1255:1995;260-266.
2. Ågren J.J., Väisänen S., Hänninen O., Muller A., Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids. 57:1997;419-421.
3. Almallah Y.Z., Ewen S.W., El-Tahir A., Mowat N.A., Brunt P.W., Sinclair T.S., Heys S.D., Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs). the mucosal effect in situ Journal of Clinical Immunology. 20:2000;68-76.
4. Alvarez R.A., Aguirre G.D., Acland G.M., Anderson R.E. Docosapentaenoic acid is converted to docosahexaenoic acid in the retinas of normal and prcd-affected miniature poodle dogs. Investigative Ophthalmology and Visual Science. 35:1994;402-408.
5. Ando K., Nagata K., Yoshida R., Kigugawa K., Suzuki M. Effect of n-3 polyunsaturated fatty acid supplementation on lipid peroxidation of rat organs. Lipids. 35:2000;401-407.
6. © oil). Food and Chemical Toxicology. 38:2000;35-49.
7. Arterburn L.M., Boswell K.D., Henwood S.M., Kyle D.J. A development safety study in rats using DHA-and ARA-rich single-cell oils. Food and Chemical Toxicology. 38:2000;763-771.
8. Ascherio A., Rimm E.B., Stampfer M.J., Giovannucci E.L., Willett W.C. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. New England Journal of Medicine. 332:1995;977-982.
9. Axelrod L., Camuso J., Williams E., Kleinman K., Briones E., Schoenfeld D. Effects of a small quantity of ω-3 fatty acids on cardiovascular risk factors in NIDDM. Diabetes Care. 17:1994;37-44.
10. Azevedo C., Corral L. Some ultrastructural observations of a thraustochytrid (Protoctista, Labyrinthulomycota) from the clam Ruditapes decussatus (Mollusca, Bivalvia). Diseases of Aquatic Organisms. 31:1997;73-78.
11. Bahnweg G. Studies on the physiology of thraustochytriales. I. Growth requirements and nitrogen nutrition of Thraustochytrium spp., Schizochytrium sp., Japonochytrium sp., Ulkenia spp., and Labyrinthuloides spp. Veröffentlichungen des Instituts für Meeresforschung in Bremerhaven. 17:1979;245-268.
12. Bang H.O., Dyerberg J., Hjørne N. The composition of food consumed by Greenland Eskimos. Acta Medica Scandinavica. 200:1976;69-73. Cited in: Bønaa et al., 1992.
13. n-3 Fatty Acids and Health. 2000;British Nutrition Foundation (BNF), London.
14. Bønaa K.H., Bjerve K.S., Nordoy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromso Study. The American Journal of Clinical Nutrition. 55:1992;1126-1134.
15. Boswell K., Koskelo E.K., Carl L., Glaza S., Hensen D.J., Williams K.D., Kyle D.J. Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid. Food and Chemical Toxicology. 34:1996;585-593.
16. 13C]22:6n-3-triacylglycerols. The American Journal of Clinical Nutrition. 64:1996;577-586.
17. Bruijntjes-Rozier, T., van Ommen, B., 2001. Bacterial Reverse Mutation Test with DHA-Oil 45. Prepared by TNO Nutrition and Food Research, Zeist at the request of Axiva GmbH Ventures, Frankfurt am Main. TNO-Report V2505/08 (Unpublished).
18. Burns R.A., Wibert G.J., Diersen-Schade D.A., Kelly C.M. Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid. 3-month rat oral safety study with an in utero phase Food and Chemical Toxicology. 37:1999;23-36.
19. Cavalier-Smith T., Allsopp M.T.E.P., Chao E.E. Thraustochytrids are chromists, not fungi. 18s rRNA signatures of heterokanta Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 346:1994;387-397.
20. Celanese Ventures, 1999. Final Report: Acute Toxicity Study of DHA-Producing Microorganism in Mice. Celanese Ventures GmbH, Frankfurt am Main, Germany (Unpublished).
21. Chanmugam P., Wheeler C., Hwang D.H. Fatty acid composition of the testes of zinc-deficient rats. the effect of docosapentaenoic acid supplementation Journal of Nutrition. 114:1984;2073-2079.
22. Charnock J.S., Turner J., McIntosh G.H. The occurrence of cardiac lipidosis and necrotic lesions in the hearts of rats following long-term feeding of different lipid supplemented diets. Journal of Nutritional Science and Vitaminology. 33:1987;75-87.
23. Cirillo F., Coppola A., Piemontinio U., Marottoli V., Amoriello A., Cerbone A.M., Stragliotto E., Tremoli E., Di Minno G., Mancini M. Platelet effects of omega 3 fatty acid ethyl esters. Galli C., Simopoulos A.P., Tremoli E. Effects of Fatty Acids and Lipids in Health and Disease. World Review of Nutrition and Dietetics, vol. 76. 1994;60-63 Karger, Basel.
24. Connor W.E. Do the n-3 fatty acids from fish prevent deaths from cardiovascular disease? The American Journal of Clinical Nutrition. 66:1997;188-189.
25. Conquer J.A., Holub B.J. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. Journal of Nutrition. 126:1996;3032-3039.
26. Conquer J.A., Holub B.J. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. Journal of Lipid Research. 39:1998;286-292.
27. Conquer J.A., Cheryk L.A., Chan E., Gentry P.A., Holub B.J. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thrombosis Research. 96:1999;239-250.
28. Danse L.H.J.C. Steatitis, subcutaneous and generalized, rat. Jones T.C., Mohr U., Hunt R.D. Integument and Mammary Glands. 1989;146-152 Springer-Verlag, Berlin. Cited in: Farwer et al., 1994.
29. Danse L.H., Steenbergen-Botterweg W.A. Early changes of yellow fat disease in mink fed a vitamin-E deficient diet supplemented with fresh or oxidised fish oil. Zentralblatt für Veterinärmedizin. 23:1976;645-660.
30. Danse L.H., Steenbergen-Botterweg W.A. Fish oil-induced yellow fat disease in rats. II. Enzyme histochemistry of adipose tissue. Veterinary Pathology. 15:1978;125-132.
31. Danse L.H., Verschuren P.M. Fish oil-induced yellow fat disease in rats. I. Histological changes. Veterinary Pathology. 15:1978;114-124.
32. Danse L.H., Verschuren P.M. Fish oil-induced yellow fat disease in rats. III. Lipolysis in affected adipose tissue. Veterinary Pathology. 15:1978;544-548.
33. Danse L.H., Stolwijk J., Verschuren P.M. Fish oil-induced yellow fat disease in rats. IV. Functional studies of the reticuloendothelial system. Veterinary Pathology. 16:1979;593-603.
34. Davidson M.H., Maki K.C., Kalkowski J., Schaefer E.J., Torri S.A., Drennan K.B. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia. a randomized, double-blind, placebo-controlled trial Journal of the American College of Nutrition. 16:1997;236-243.
35. Dolecek T.A., Grandits G. Dietary polyunsaturated fatty acids and mortality in Multiple Risk Factor Intervention Trial (MRFIT). Simopoulos A.P., Kifer R.R., Martin R.E., Barlow S. Health Effects of Omega 3 Polyunsaturated Fatty Acids in Seafoods. 2nd International Conference Proceedings, March, 1990, Washington, DC. World Review of Nutrition and Dietetics, vol. 66. 1991;205-216 Karger, Basel.
36. Engström K., Luostarinen R., Saldeen T. Whole blood production of thromboxane, prostacyclin and leukotriene B(4) after dietary fish oil supplementation in man. effect on vitamin E Prostaglandins, Leukotrienes and Essential Fatty Acids. 54:1996;419-425.
37. Eritsland J., Seljeflot M., Abdelnoor M., Arnesen H. Long-term influence of omega-3 fatty acids on fibrinoylsis, fibrinogen, and serum lipids. Fibrinolysis. 8:1994;120-125.
38. European Register of Marine Species, 2001. [Labyrinthulids and Thaustrochytrids, etc.]. In: The European Register of Marine Species. European Union, MAST (Marine Science and Technology) Programme, Dublin. Available from http://erms.biol.soton.ac.uk/ .
39. Farwer S.R., Der Boer B.C., Haddeman E., Kivits G.A., Wiersma A., Danse B.H. The vitamin E nutritional status of rats fed on diets high in fish oil, linseed oil or sunflower seed oil. British Journal of Nutrition. 72:1994;127-145.
40. Fluge Ø., Omenaas E., Eide G.E., Gulsvik A. Fish consumption and respiratory symptoms among young adults in a Norwegian community. European Respiratory Journal. 12:1998;336-340.
41. Foegh M.L., Hecker M., Ramwell P.W. The eicosanoids. prostaglandins, thromboxanes, leukotrienes, and related compounds Katzung B.G. Basic and Clinical Pharmacology, seventh ed. 1998;304-318 Appleton & Lange, Stamford.
42. Fujii, W., Suwa, Y., 1998a. Final Report. 2) Mutagenicity Data. Prepared by Institute for Fundamental Research Suntory Ltd (Unpublished).
43. Fujii, W., Suwa, Y., 1998b. Final Report, 1) Acute Toxicology Data. Prepared by Institute for Fundamental Research Suntory Ltd (Unpublished).
44. Fujii, W., Suwa, Y., 1999. Final Report: Mutagenicity Study of DHA-Producing Microorganism. Prepared by Institute for Fundamental Research Suntory Ltd. Report No. HMS-96-14 (Unpublished).
45. Gogos C.A., Ginopoulos P., Salsa B., Apostolidou E., Zoumbos N.C., Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. a randomized control trial Cancer. 82:1998;395-402.
46. Goh Y.K., Jumpsen J.A., Ryan E.A., Clandinin M.T. Effect of-3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia. 40:1997;45-52.
47. Green J., Bunyan J. Vitamin E and the biological antioxidant theory. Nutrition Abstracts and Reviews. 39:1969;321-345. Cited in: Danse and Verschuren, 1978a.
48. Grimsgaard S., Bønaa K.H., Hansen J.B., Nordøy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. The American Journal of Clinical Nutrition. 66:1997;649-659.
49. Grimsgaard S., Bønaa K.H., Hansen J.-B., Myhre E.S.P. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. The American Journal of Clinical Nutrition. 68:1998;52-59.
50. Guyton A.C., Hall J.E. Digestion and absorption in the gastrointestinal tract. Guyton A.C., Hall J.E. Textbook of Medical Physiology, ninth ed. 1996;833-844 W.B. Saunders Company, Philadelphia.
51. Haglund O., Luostarinen R., Wallin R., Saldeen T. Effects of fish oil on triglycerides, cholesterol, lipoprotein(a), atherogenic index and fibrinogen. Influence of degree of purification of the oil. Nutrition Research. 12:1992;455-468.
52. Haglund O., Wallin R., Wretling S., Hultberg B., Saldeen T. Effects of fish oil alone and combined with long chain (n-6) fatty acids on some coronary risk factors in male subjects. The Journal of Nutritional Biochemistry. 9:1998;629-635.
53. Hamazaki T., Sawazaki S., Asaoka E., Itomura M., Mizushima Y., Yazawa K., Kuwamori T., Kobayashi M. Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. Journal of Nutrition. 126:1996;2784-2789.
54. Hammond B.G., Mayhew D.A., Naylor M.W., Ruecker F.A., Mast R.W., Sander W.J. Safety assessment of DHA-rich microalgae from Schizochytrium sp. I. Subchronic rat feeding study. Regulatory Toxicology and Pharmacology. 33:2001;192-204.
55. Hammond B.G., Mayhew D.A., Robinson K., Mast R.W., Sander W.J. Safety assessment of DHA-rich microalgae from Schizochytrium sp. III. Single-generation rat reproduction study. Regulatory Toxicology and Pharmacology. 33:2001;356-362.
56. Hammond B.G., Mayhew D.A., Holson J.F., Nemec M.D., Mast R.W., Sander W.J. Safety assessment of DHA-rich microalgae from Schizochytrium sp. II. Developmental toxicity evaluation in rats and rabbits. Regulatory Toxicology and Pharmacology. 33:2001;205-217.
57. Hansen J.B., Grimsgaard S., Nilsen H., Nordøy A., Bønaa K.H. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids. 33:1998;131-138.
58. Health and Welfare Canada, 1990. Table 19. Summary of examples of recommended nutrients based on energy expressed as daily rates. In: Nutrition Recommendations - The Report of the Scientific Review Committee. Health and Welfare Canada, Scientific Review Committee, Ottawa, pp. 203 (H49-42/1990E).
59. Helgebostad A., Ender F. Vitamin E and its function in the health and disease of fur bearing animals. Acta Agriculturae Scandinavica. (Suppl. 19):1973;79-83.
60. Hempenius R.A., Van Delft J.M.H., Prinsen M., Lina B.A.R. Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina. summary of toxicological data Food and Chemical Toxicology. 35:1997;573-581.
61. Hempenius R.A., Lina B.A.R., Haggitt R.C. Evaluation of a subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonic acid oil derived from Mortierella alpina in rats. Food and Chemical Toxicology. 38:2000;127-139.
62. Henderson W.R., Astley S.J., McCready M.M., Kushmerick P., Casey S., Becker J.W., Ramsey B.W. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. Journal of Pediatrics. 124:1994;400-408.
63. Honda D., Yokochi T., Nakahara T., Raghukumar S., Nakagiri A., Schaumann K., Higashihara T. Molecular phylogeny of labyrinthulids and thraustochytrids based on the sequencing of 18S ribosomal RNA gene. The Journal of Eukaryotic Microbiology. 46:1999;637-647.
64. Horrocks L.A., Yeo Y.K. Docosahexaenoic acid-enriched foods. production and effects on blood lipids Lipids. 34(Suppl.):1999;S313.
65. Hsia, M.T.S., Marvis, R.D., DeSesso, J.M., 1989. Health Effects of Refined Menhaden Oil. Prepared by Mitre Corp., Civil Systems Division, McLean, Virginia for US Food and Drug Administration (US FDA), Washington, DC (PB89-182398).
66. Innis S.M., Hansen J.W. Plasma fatty acid responses, metabolic effects, and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults. The American Journal of Clinical Nutrition. 64:1996;159-167.
67. IOM, 2002. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Protein and Amino Acids (Macronutrients). National Academy of Sciences, Food and Nutrition Board, Institute of Medicine (IOM). National Academy Press (NAP), Washington, DC, pp. 335-432.
68. ISSFAL, 1999. Adequate Intakes. International Society for the Study of Fatty Acids and Lipids (ISSFAL), Devon. ( http://www.issfal.org.uk/adequateintakes.htm ).
69. Johansson L.R., Solvoll K., Bjorneboe G.E., Drevon C.A. Intake of very-long-chain n-3 fatty acids related to social status and lifestyle. European Journal of Clinical Nutrition. 52:1998;716-721.
70. Jones D., Howard A.N., Gresham G.A. Aetiology of 'yellow fat' disease (pansteatitis) in the wild rabbit. Journal of Comparative Pathology. 79:1969;329-334.
71. Jonnalagadda S.S., Egan S.K., Heimbach J.T., Harris S.S., Kris-Etherton P.M. Fatty acid consumption pattern of Americans. 1987-1988 USDA Nationwide Food Consumption Survey Nutrition Research. 15:1995;1767-1781.
72. Kashima, M., Sarwar, G., 2000. Final Report. Chromosomal Aberration Test of DHA-Oil in Cultured Chinese Hamster Cells. Prepared by Nippon Experimental Medical Research Institute Co., Ltd., Gunma-ken, Japan. Project No. H-99144 (Unpublished).
73. Kelley D.S., Rudolph I.L. Effect of individual fatty acids of ω-6 and ω-3 type on human immune status and role of eicosanoids. Nutrition. 16:2000;143-145.
74. Kelley D.S., Taylor P.C., Nelson G.J., Mackey B.E. Dietary docosahexaenoic acid and immunocompetence in young healthy men. Lipids. 33:1998;559-566.
75. Kelley D.S., Taylor P.C., Nelson G.J., Schmidt P.C., Ferreti A., Erickson K.L., Yu R., Chandra R.K., Mackey B.E. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids. 34:1999;317-324.
76. Kris-Etherton P.M., Taylor D.S., Yu-Poth S., Huth P., Moriarty K., Fishell V., Hargrove R.L., Zhao G., Etherton T.D. Polyunsaturated fatty acids in the food chain in the United States. The American Journal of Clinical Nutrition. 71(Suppl.1):2000;179S-188S.
77. Krummel, D., 1996. Lipids [and] polyunsaturated fatty acids. In: Mahan, L.K., Escott-Stump, S. (Eds.), Krause's Food, Nutrition and Diet Therapy, ninth ed. W.B. Saunders Company, Philadelphia, pp. 49-62 and 528.
78. Kuilman, M.E.M., Waalkens-Berendsen, D.H., 2001. Oral One-Generation Reproduction Study with DHA Oil 45 in Rats. Prepared by TNO Nutrition and Food Research, The Netherlands for Celanese Ventures GmbH, Germany. Project No. 41089, TNO Study No. 2633 (Unpublished).
79. Leaf A., Jorgensen M.B., Jacobs A.K., Cote G., Schoenfeld D.A., Scheer J., Weiner B.H., Slack J.D., Kellett M.A., Raizner A.E., Weber P.C., Mahrer P.R., Rossouw J.E. Do fish oils prevent restinosis after coronary angioplasty? Circulation. 90:1994;2248-2257.
80. Linder M.C. Nutrition and metabolism of fats. Linder M.C. Nutritional Biochemistry and Metabolism with Clinical Applications, second ed. 1991;51-84 Elsevier Science Publishing Company, New York.
81. Linscheer W.G., Vergroesen A.J. Lipids. Shils M.E., Olson J.A., Shike M. Modern Nutrition in Health and Disease, vol. 1, eighth ed. 1994;47-88 Lea & Febiger, Philadelphia.
82. Losco P. Normal development, growth, and aging of the spleen. Mohr U., Dungworth D.L., Capen C.C. Pathobiology of the Aging Rat. Vol. 1. Blood and Lymphoid, Respiratory, Urinary, Cardiovascular, and Reproductive Systems. 1992;75-94 ILSI Press, Washington, DC.
83. Luostarinen R., Wallin R., Wibell L., Saldeen T. Vitamin E supplementation counteracts the fish oil-induced increase of blood glucose in humans. Nutrition Research. 15:1995;953-968.
84. McGuire S.O., Alexander D.W., Fristche K.L. Fish oil source differentially affects rat immune cell α-tocopherol concentration. Journal of Nutrition. 127:1997;1388-1394.
85. McManus R.M., Jumpson J., Finegood D.T., Clandinin M.T., Ryan E.A. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care. 19:1996;463-467.
86. Mori T.A., Beilin L.J., Burke V., Morris J., Ritchie J. Interactions between dietary fat, fish and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arteriosclerosis, Thrombosis and Vascular Biology. 17:1997;279-286.
87. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. The American Journal of Clinical Nutrition. 71:2000;1085-1094.
88. Mori T.A., Vandongen R., Mahanian F., Douglas A. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism. 41:1992;1059-1067.
89. Muggli R. Physiological requirements of vitamin E as a function of the amount and type of polyunsaturated fatty acid. Galli C., Simopoulos A.P., Tremoli E. Fatty Acids and Lipids: Biological Aspects. Proceedings of the 1st International Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL). World Review of Nutrition and Dietetics, vol. 75. 1994;166-168 Karger, Basel.
90. Naganuma T., Takasugi H., Kimura H. Abundance of thraustochytrids in coastal plankton. Marine Ecology (Progress Series). 162:1998;105-110.
91. Neda, K., 2000a. An Acute Oral Toxicity of DHA-Containing Lipid in Rats. Celanese Ventures GmbH, Frankfurt am Main, Germany (Unpublished).
92. Neda, K., 2000b. Final Report: A 90-Day Repeated Oral Dose Toxicity Study of DHA-Containing Lipid in Rats. Prepared by Nippon Experimental Medical Research Institute Co., Ltd., Gunma-ken, Japan. Project No. H-99142 (Unpublished).
93. Nelson G.J., Schmidt P.C., Bartolini G.L., Kelly D.S., Kyle D. The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids. 32:1997;1137-1146.
94. Neuringer M., Anderson G.J., Connor W.E. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annual Review of Nutrition. 8:1988;517-541.
95. Oarada M., Furukawa H., Majima T., Miyazawa T. Fish oil diet affects on oxidative senescence of red blood cells linked to degeneration of spleen cells in mice. Biochimica et Biophysica Acta. 1487:2000;1-14.
96. Parkinson A.J., Cruz A.L., Heyward W.L., Bulkow L.R., Hall D., Barstaed L., Connor W.E. Elevated concentrations of plasma-3 polyunsaturated fatty acids among Alaskan eskimos. The American Journal of Clinical Nutrition. 59:1994;384-388.
97. Périchon R., Bourre J.M. Peroxisomal β-oxidation activity and catalase activity during development and aging in mouse liver. Biochimie. 77:1995;288-293.
98. Pollard L., Sanders T.A.B. Estimates of the vitamin E requirement in rats fed long-chain ω-3 fatty acids. The Proceedings of the Nutrition Society. 52:1993;319. A.
99. Rabbani P.I., Sheikh N.M., Chirtel S.J., Jackson R., Ruffin G. Effects of long-term consumption of high doses of fish oil concentrates on clinical parameters in male and female rats. Journal of Nutritional Science and Vitaminology. 45:1999;553-565.
100. Retterstøl K., Haugen T.B., Christophersen B.O. The pathway from arachidonic to docosapentaenoic acid (20:4n-6 to 22:5n-6) and from eicosapentaenoic to docosahexaenoic acid (20:5n-3 to 22:6n-3) studied in testicular cells from immature rats. Biochimica et Biophysica Acta. 1483:2000;119-131.
101. Rosenthal M.D., Garcia M.C., Jones M.R., Sprecher H. Retroconversion and delta(4) desaturation of docosatetraenoate (22:4(n-6)) and docosapentaenoate (22:5(n-3)) by human cells in culture. Biochimica et Biophysica Acta. 1083:1991;29-36.
102. Ruiter A., Jongbloed A.W., van Gent C.M., Danse L.H., Metz S.H. The influence of dietary mackerel oil on the condition of organs and on blood lipid composition in the young growing pig. The American Journal of Clinical Nutrition. 31:1978;2159-2166.
103. Sanders T.A.B. Effects of fish oils on lipid metabolism. Nutrition. 5:1989;248-250.
104. Sathe-Pathak V., Raghukumar S., Raghukumar C., Sharma S. Thraustochytrid and fungal component of marine detritus. I. Field studies on decomposition of the brown alga Sargassum cinereum J. Ag. Indian Journal of Marine Sciences. 22:1993;159-167.
105. Schloss I., Kidd M.S., Tichelaar H.Y., Young G.O., O'Keefe S.J. Dietary factors associated with a low risk of colon cancer in coloured west coast fishermen. South African Medical Journal. Suid-Afrikaanse Tydskrif vir Geneeskunde. 87:1997;152-158.
106. Schmidt E.B., Lervang H.H., Varming K., Madsen P., Dyerberg J. Long-term supplementation with n-3 fatty acids, I. effect on blood lipids, haemostasis and blood pressure Scandinavian Journal of Clinical Laboratory Investigation. 52:1992;221-228.
107. Sugano M., Hirahara F. Polyunsaturated fatty acids in the food chain in Japan. The American Journal of Clinical Nutrition. 71(Suppl.1):2000;189S-196S.
108. Torres I.C., Mira L., Ornelas C.P., Melim A. Study of the effects of dietary fish intake on serum lipids and lipoproteins in two populations with different dietary habits. The British Journal of Nutrition. 83:2000;371-379.
109. Tremoli E., Maderna P., Marangoni F., Colli S., Eligini S., Catalano I., Angeli M.T., Pazzucconi F., Gianfranceschi G., Davi G., Stragliotto E., Sirtori C.R., Galli C. Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers. The American Journal of Clinical Nutrition. 61:1995;607-613.
110. Turini M.E., Powell W.S., Behr S.R., Holub B.J. Effects of a fish-oil and vegetable-oil formula on aggregation and ethanolamine-containing lysophospholipid generation in activated human platelets and on leukotriene production in stimulated neutrophils. The American Journal of Clinical Nutrition. 60:1994;717-724.
111. Ulken A., Víquez R., Valient C., Campos M. Marine fungi (Chytridiomycetes and Thraustochytriales) from a mangrove area at Punta Morales, Golfo de Nicoya, Costa Rica. Revista de Biologia Tropical. 38:1990;243-250.
112. US FDA, 1989. Substances Affirmed as Generally Recognized as Safe: Hydrogenated and Partially Hydrogenated Menhaden Oils; Final Rule (21 CFR, Part 184, Docket No. 86G-0289). US Federal Register 54, 38219.
113. US FDA, 1993. Food Labeling: Health Claims and Label Statements: Omega-3 Fatty Acids and Coronary Heart Disease; Final Rule (21 CFR, Part 101, Docket No. 91N-0103, RIN 0905-AB67). US Federal Register 58, 2682.
114. US FDA, 1997. Substances Affirmed as Generally Recognized as Safe: Menhaden Oil; Final Rule (21 CFR, Part 184, Docket No. 86G-0289). US Federal Register 62, 30751-30757.
115. US FDA, 2000. Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease (Docket No. 91N-0103). US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Nutritional Products, Labeling, and Dietary Supplements.
116. US FDA, 2001. Agency Response Letter GRAS Notice No. GRN 000041. US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Food Additive Safety.
117. USDA, 2000. 1994-1996, 1998 Continuing Survey of Food Intakes by Individuals (CSF II) and Diet and Health Knowledge Survey (DHKS) (On CD-ROM). US Department of Agriculture (USDA), Riverdale (PB2000-500027).
118. Verschuren P.M., Houtsmuller U.M., Zevenbergen J.L. Evaluation of vitamin E requirement and food palatability in rabbits fed a purified diet with a high fish oil content. Laboratory Animals. 24:1990;164-171.
119. Wibert G.J., Burns R.A., Diersen-Schade D.A., Kelly C.M. Evaluation of single cell sources of docosahexaenoic acid and arachidonic acid. a 4-week oral safety study in rats Food and Chemical Toxicology. 35:1997;967-974.
120. Willumsen N., Hexeberg S., Skorve J., Lindquist M., Berge R.K. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. Journal of Lipid Research. 34:1993;13-22.
121. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., Calder P.C. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. European Journal of Clinical Investigation. 30:2000;260-274.